Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Mirati Research Site
Birmingham Alabama 35294-3300

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
Huntsville Alabama 35805-2606

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

View More ▼

Birmingham Alabama 35249

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Birmingham Alabama 35233

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Birmingham Alabama 35205

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Birmingham Alabama 35233

A clinical trial to evaluate treatments using TRC105 for patients with Lung Cancer, Non-Squamous Cell Lung Cancer (NSCLC)

Arizona

Phoenix Arizona 85016

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Prescott Valley Arizona 86314

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Scottsdale Arizona 85258

A clinical research study of carboplatin, paclitaxel and paclitaxel poliglumex for the treatment of Lung Cancer

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

View More ▼

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Tucson Arizona 85704

A clinical trial to evaluate treatments using Nivolumab in combination with Ipilimumab for patients with Lung Cancer

Arkansas

Genesis Cancer Center
Hot Springs Arkansas 71913

G1T28 in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

Mirati Research Site
Jonesboro Arkansas 72401

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

View More ▼

Jonesboro Arkansas 72401

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

Little Rock Arkansas 72205

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

California

Mirati Research Site
Burbank California 91505

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
La Jolla California 92093

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
Loma Linda California 92354

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
Los Angeles California 90073

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
San Francisco California 94115

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Incyte Corporation
Whittier California

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mirati Research Site
Whittier California 90603

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

View More ▼

Anaheim California 92801

A clinical research study of darbepoetin alfa 500 mcg Q3W and placebo for the treatment of Non-Small Cell Lung Cancer, Anemia, Cancer or Lung Cancer

Bakersfield California 93309

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Burbank California 91505

A clinical research study of carboplatin, paclitaxel and paclitaxel poliglumex for the treatment of Lung Cancer

Duarte California 91010

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Bone Metastases

Duarte California

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating NEO-PV-01, Nivolumab and Adjuvant

Escondido California 92025-4404

A clinical research study of carboplatin, paclitaxel and paclitaxel poliglumex for the treatment of Lung Cancer

Fullerton California 92835

A clinical trial to evaluate treatments using Nivolumab for patients with Lung Cancer

Irvine California

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

La Jolla California 92037-0845

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

La Jolla California 92093

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

La Jolla California 92037

A clinical research study of Crizotinib and Pembrolizumab for the treatment of ALK-positive Advanced Non-Small Cell Lung Cancer (NSCLC)

La Jolla California 92093-0658

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Loma Linda California 92354

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

Long Beach California 90813

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab